FDA published alerts and recall notices regarding pump safety, involving Baxter and Goldman Sachs.
1 report, 1 independent
Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA published alerts and recall notices regarding pump safety, involving Baxter and Goldman Sachs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Goldman Sachs
American investment bank
-
Baxter International
American manufacturer of healthcare goods
Nothing else this week.
Related events
- The Food and Drug Administration (FDA) oversees product safety and recalls.
- FDA issues warnings leading to product recalls in Texas.
- FDA safety warnings have been issued, causing caution among clinicians.
- FDA is overseeing food safety recalls and monitoring products sold at Walmart stores.
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
Coverage
Newest first; wire copies grouped- MedTech DiveBaxter recalls certain Novum pumps over issues tied to 79 injuries, 2 deaths This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTe